Ubiquinol (reduced Coenzyme Q10) in patients with severe sepsis or septic shock: a randomized, double-blind, placebo-controlled, pilot trial

INTRODUCTION: We previously found decreased levels of Coenzyme Q10 (CoQ10) in patients with septic shock. The objective of the current study was to assess whether the provision of exogenous ubiquinol (the reduced form of CoQ10) could increase plasma CoQ10 levels and improve mitochondrial function. M...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Crit Care
Päätekijät: Donnino, Michael W., Mortensen, Sharri J., Andersen, Lars W., Chase, Maureen, Berg, Katherine M., Balkema, Julia, Radhakrishnan, Jeejabai, Gazmuri, Raúl J., Liu, Xiaowen, Cocchi, Michael N.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2015
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4520066/
https://ncbi.nlm.nih.gov/pubmed/26130237
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-015-0989-3
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia